2024-04-30 15696959 2025-04-30 15696959 2024-04-30 2025-04-30 15696959 uk-core:WithinOneYear 2025-04-30 15696959 uk-core:ShareCapital 2025-04-30 15696959 uk-core:RetainedEarningsAccumulatedLosses 2025-04-30 15696959 uk-bus:Director1 2024-04-30 2025-04-30 15696959 uk-core:ComputerEquipment 2024-04-30 2025-04-30 15696959 2 uk-bus:Director1 2024-04-30 2025-04-30 15696959 2 uk-bus:Director1 2025-04-30 iso4217:GBP xbrli:pure 15696959 uk-bus:AuditExemptWithAccountantsReport 2024-04-30 2025-04-30 15696959 uk-bus:FRS102 2024-04-30 2025-04-30 15696959 uk-bus:FullAccounts 2024-04-30 2025-04-30 15696959 uk-bus:PrivateLimitedCompanyLtd 2024-04-30 2025-04-30

JB Med Ltd

Registered Number:15696959

For the period ended 30 April 2025
England and Wales
Unaudited Financial Statements

2
For the period ended 30 April 2025
JB Med Ltd
Contents Page
1
Statement of Financial Position
2 to 3
Notes to the Financial Statements
3

Registered Number :

15696959

As at 30 April 2025

JB Med Ltd
Statement of Financial Position

£

2025

Notes

Fixed assets

Property, plant and equipment

750
2
750

Trade and other payables: amounts falling due within one
year

(788)
3
(788)
Net current liabilities

Total assets less current liabilities

(38)
(142)

Provisions for liabilities

(180)
Net assets/liabilities

Capital and reserves

Called up share capital

1

Retained earnings

(181)
(180)
Shareholders' funds

For the period ended 30 April 2025 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the period ended 30 April 2025 in accordance with Section 476 of the Companies Act 2006

The director acknowledges his responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Section
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

J A Butler Director

These financial statements were approved and authorised for issue by the Board on 22 October 2025 and were signed by:

The notes form part of these financial statements

1 of 3
4
For the period ended 30 April 2025
JB Med Ltd
Notes to the Financial Statements
Statutory Information

JB Med Ltd is a private limited company, limited by shares, domiciled in England and Wales, registration number
15696959.

Registered address:

32 Causeway View
Plymouth
Devon
PL9 9FP

The presentation currency is £ sterling.

1. Accounting policies

Basis of preparing the financial statements

These financial statements have been prepared in accordance with the provisions of Section 1 A of Financial
Reporting Standard 102 ''The Financial Reporting Standard applicable in the UK and Republic of Ireland'' and the
Companies Act 2006. The financial statements have been prepared under the historical costs convention.

Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates.
Property, plant and equipment

Property, plant and equipment are stated at cost less depreciation. Depreciation is provided at rates calculated to write off the cost of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:

25% Reducing balance

Computer Equipment

2. Property, plant and equipment

Computer
Equipment

£

Cost or
valuation

1,000

Additions

At 30 April 2025

1,000

Provision for depreciation and impairment

Charge for period
250

At 30 April 2025

250

At 30 April 2025

Net book value

750
2 of 3
5
For the period ended 30 April 2025
JB Med Ltd
Notes to the Financial Statements Continued

3. Trade and other payables: amounts falling due within one year

2025

£

Other creditors

788

4. Related party transactions

The company is under the effective control of its director.

5. Directors advances and guarantees

Loaned
Repaid

At 30/04/2025

£

£

£

J A Butler
Loan to the director
(248)
6,159
6,407
(248)
6,159
6,407

6. Average number of persons employed

During the period the average number of employees was 1
3 of 3